ALTERED ALVEOLAR SURFACTANT IS AN EARLY MARKER OF ACUTE LUNG INJURY IN SEPTIC ADULT SHEEP

Citation
Jf. Lewis et al., ALTERED ALVEOLAR SURFACTANT IS AN EARLY MARKER OF ACUTE LUNG INJURY IN SEPTIC ADULT SHEEP, American journal of respiratory and critical care medicine, 150(1), 1994, pp. 123-130
Citations number
38
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
ISSN journal
1073449X
Volume
150
Issue
1
Year of publication
1994
Pages
123 - 130
Database
ISI
SICI code
1073-449X(1994)150:1<123:AASIAE>2.0.ZU;2-5
Abstract
The purpose of this study was to characterize changes in the endogenou s surfactant system in adult sheep rendered septic via cecal ligation and perforation (CLP). Forty-eight hours after CLP, septic animals had significant increases in mean pulmonary artery pressure (PAP) (p < 0. 01), cardiac index (Cl) (p < 0.01), and arterial lactate (p < 0.05) va lues compared with their respective baseline values, while the same me asurements in a sham-operated control group did not change significant ly. The changes in the septic group were associated with significantly lower Pa-O2 (p < 0.05) and alveolar to arterial (A-a) oxygen gradient values (P < 0.01) at 48 h compared with baseline measurements. No cha nges in oxygenation occurred within the sham-operated group. Surfactan t phospholipid (PL) composition and surface activity measurements of i solated alveolar surfactant aggregate forms were similar for the two g roups at 48 h. However, the ratio of poorly functioning small aggregat e forms (SA) to superior functioning large aggregates (LA) was signifi cantly increased in the septic versus the sham-operated animals (p < 0 .01). This was associated with significantly decreased surfactant prot ein A (SP-A), B (SP-B), and C (SP-C) levels in septic versus sham-oper ated animals (p < 0.05). We conclude that sepsis-associated lung injur y resulted in altered alveolar surfactant aggregate forms. These chang es, together with altered surfactant protein levels, may represent a v ery sensitive marker of acute lung injury in high-risk patients. Furth ermore, these findings suggest that exogenous surfactant given at an e arly stage of lung injury may mitigate progressive lung dysfunction.